Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5209488
Max Phase: Preclinical
Molecular Formula: C23H19N3O3
Molecular Weight: 385.42
Associated Items:
ID: ALA5209488
Max Phase: Preclinical
Molecular Formula: C23H19N3O3
Molecular Weight: 385.42
Associated Items:
Canonical SMILES: CCOc1ccc(C(=O)Oc2cncc(-c3cnn(-c4ccccc4)c3)c2)cc1
Standard InChI: InChI=1S/C23H19N3O3/c1-2-28-21-10-8-17(9-11-21)23(27)29-22-12-18(13-24-15-22)19-14-25-26(16-19)20-6-4-3-5-7-20/h3-16H,2H2,1H3
Standard InChI Key: UYDKGSBKLBBYKR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 385.42 | Molecular Weight (Monoisotopic): 385.1426 | AlogP: 4.55 | #Rotatable Bonds: 6 |
Polar Surface Area: 66.24 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.26 | CX LogP: 4.35 | CX LogD: 4.35 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.46 | Np Likeness Score: -1.52 |
1. Eguida M, Schmitt-Valencia C, Hibert M, Villa P, Rognan D.. (2022) Target-Focused Library Design by Pocket-Applied Computer Vision and Fragment Deep Generative Linking., 65 (20.0): [PMID:36256484] [10.1021/acs.jmedchem.2c00931] |
Source(1):